Alembic gets FDA blessing for generic Macrodantin

Nitrofurantoin capsules have a market value of roughly $23 million for the 12 months ended March 2021, according to IQVIA.
Levy

Alembic has obtained the Food and Drug Administration’s approval for nitrofurantoin (macrocrystals) capsules, in dosage strengths of  25 mg, 50 mg and 100 mg.

The product is the generic of Alvogen Malta Operations’ Macrodantin capsules.

The medication is indicated for the treatment of urinary tract infections due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species.

Nitrofurantoin capsules have a market value of roughly $23 million for the 12 months ended March 2021, according to IQVIA.

X
This ad will auto-close in 10 seconds